Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Comment by regardlesson Aug 25, 2018 1:25pm
106 Views
Post# 28517158

RE:What I do Like

RE:What I do LikeWhat I like is this too..
if the prospectus was going to be filled much lower than ten cents a share this stock would reflect that..
heres another thing
if the prospectus is 25 mill then they would have to issue 250million shares at ten cents a share ...
i k ow for a fact that they will not do that lol..

sothink about that ...prospectus could be offered in fact at a much higher evaluation that our current share price....
think about that for a minute and it makes way more sense.....
this company is not gonna go from 89 million share float to 340 million shares ...

my math and opinion says says that we get the prospectus filed at around 50 cents a share with conditional offers and approval that Benefits the buyer who we yet don’t know who it is....

either that or or a partner is in the works with limited dilutions....either scenario raises the share price considerably 
<< Previous
Bullboard Posts
Next >>